Statins, primary prevention, and overall mortality

Annals of Internal Medicine

Volumn 160, Issue 12, 2014, Pages 867-869

  Prasad, Vinay ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ATORVASTATIN; CERIVASTATIN; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; ROSUVASTATIN;

ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; NOTE; POPULATION; PRIMARY PREVENTION; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK MANAGEMENT; SECONDARY PREVENTION; SURVIVAL;

HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; META-ANALYSIS AS TOPIC; MORTALITY; PRIMARY PREVENTION;

EID: 84902665589     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M13-2974     Document Type: Note

References (10)

1. Robinson JG. Accumulating evidence for statins in primary prevention [Editorial]. JAMA. 2013;310:2405-6. [PMID: 24276744]
2. Redberg RF, Katz MH. Healthy men should not take statins. JAMA. 2012;307:1491-2. [PMID: 22496261]
3. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195-207. [PMID: 18997196]
4. Ray KK, Seshasai SR, Erqou S, Sever P, Jukema JW, Ford I, et al. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants. Arch Intern Med. 2010;170:1024-31. [PMID: 20585067]
5. Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;1:CD004816. [PMID: 23440795]
6. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333:1301-7. [PMID: 7566020]
7. Ford I, Murray H, Packard CJ, Shepherd J, Macfarlane PW, Cobbe SM; West of Scotland Coronary Prevention Study Group. Long-term follow-up of the West of Scotland Coronary Prevention Study. N Engl J Med. 2007;357:1477-86. [PMID: 17928595] (Pubitemid 47572633)
8. Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, et al Cholesterol Treatment Trialists' (CTT) Collaborators. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380:581-90. [PMID: 22607822]
9. Newman DH, Saini V, Brody H, Brownlee S, Hoffman JR, Redberg RF, et al. Statins for people at low risk of cardiovascular disease [Letter]. Lancet. 2012;380:1814; author reply 1817-8. [PMID: 23177692]
10. National Conference of State Legislatures. Automatic recount. Denver: National Conference of State Legislatures; 2010. Accessed at www.ncsl.org/research/elections-and-campaigns/automatic-recount-thresholds.aspx on 20 November 2013.